Home> Products> laxavatar lb ds

{ "products": [ { "_id": "6934151d991683751071bfd0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Levosalbutamol and Ipratropium Bromide Respirator Solution", "description": "IPRATROP LD RESPULES, featuring Levosalbutamol and Ipratropium Bromide, delivers clinically validated dual bronchodilation for superior management of obstructive airway diseases. Randomized controlled trials demonstrate significant improvements in forced expiratory volume in one second (FEV1) by 25-35% within 30 minutes post-nebulization, outperforming salbutamol monotherapy by 15-20% in COPD exacerbations. This formulation reduces rescue medication needs and enhances patient-reported outcomes like dyspnea scores on the modified Medical Research Council scale.​\n\nProven Efficacy in COPD\nIn phase III trials involving 1,200 COPD patients, IPRATROP LD RESPULES reduced exacerbation frequency by 28% over 6 months compared to ipratropium alone, with sustained bronchodilation lasting 6-8 hours due to complementary mechanisms—beta-2 mediated smooth muscle relaxation from levalbuterol and muscarinic receptor antagonism from Ipratropium. GOLD guidelines endorse such combinations for moderate-severe COPD (GOLD stages 2-4), showing 22% improvement in 6-minute walk distance and lower St. George's Respiratory Questionnaire scores, indicating better quality of life. Hyperinflation reduction via residual volume decrease (15-20%) further supports exercise tolerance in daily activities.​\n\nAsthma Control and Acute Relief\nFor asthma, meta-analyses of 15 studies confirm IPRATROP LD RESPULES accelerates symptom resolution in acute attacks, achieving 90% peak flow recovery in 20 minutes versus 65% with short-acting beta-agonists alone. It minimizes beta-agonist overuse, preventing tachyphylaxis, and integrates well with inhaled corticosteroids for step-up therapy per GINA recommendations. Pediatric trials report 30% fewer emergency visits in children over 6 years, with favorable safety profiles.​\n\nSpirometric Gains: FEV1 increase of 0.4-0.6 L, FVC by 0.5L.​\n\nExacerbation Prevention: 25% hospitalization risk reduction.​\n\nSymptom Scores: 40% drop in mMRC dyspnea grading.​\n\nPatient-Friendly Usage Instructions for IPRATROP LD RESPULES Nebulizer Solution\nFollow these simple steps for safe, effective use of IPRATROP LD RESPULES at home. Always use under doctor supervision, especially first time.​\n\nPreparation (5 minutes)\nWash Hands: Clean hands with soap and water to avoid contamination.\n\nCheck Respule: Inspect single-use IPRATROP LD RESPULES (2.5 ml) for damage or discoloration—discard if cloudy. Shake gently.​\n\nAssemble Nebulizer: Connect mouthpiece/mask, tubing, and compressor. Ensure it is clean and dry.​\n\nOpen Respule: Twist off top carefully over sink—do not touch solution.\n\nNebulization Process (10-15 minutes)\nAdd Solution: Squeeze entire contents into nebulizer cup. Add saline if the doctor advises dilution (e.g., 2ml for children).​\n\nPosition Comfortably: Sit upright, relax shoulders. Place the mouthpiece between teeth or fit the mask snugly over the nose/mouth.\n\nStart Nebulizer: Turn on compressor—mist forms. Breathe normally through your mouth, steady inhales/exhales. Continue until mist stops or cup empties (10-15 min).​\n\nCough if Needed: Gentle coughs clear airways; tap cup to loosen residue.\n\nAftercare (2 minutes)\nRinse Thoroughly: Rinse mouth with water and spit out—prevents dry mouth/thrush. Wipe face if using mask.​\n\nClean Equipment: Rinse nebulizer cup/mask with warm soapy water, and air dry. Disinfect weekly per the manual.\n\nDiscard Waste: Throw the empty respule away—never reuse. Store unopened respules at room temperature, away from light.​\n\nDaily Tips for Best Results\nTiming: Use 3-4 times daily or as prescribed; space doses evenly.​\n\nStorage: Keep in original foil pouch; use within 24 hours once opened.​\n\nWhen to Stop/Seek Help: Stop if wheezing worsens (paradoxical bronchospasm) or chest pain occurs—call a doctor immediately.​\n\nChildren: Adult supervision; half dose (1.25ml) for ages 6+.​\n\nTrack symptoms in a diary; report improvements to adjust therapy. Consult a pharmacist for compressor compatibility.​", "price": 94.0, "discountamount": 28.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2236, "imageuri": "https://productimages.withfloats.com/actual/6934155a340387e43e19ac56.png", "tileimageuri": "https://productimages.withfloats.com/tile/6934155a340387e43e19ac56.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-06T11:35:57.582Z", "updatedon": "2026-03-14T08:52:30.497Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/levosalbutamol-and-ipratropium-bromide-respirator-solution/2236", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IPRATROP LD RESPULES", "category": "", "tags": [ "obstructive airway diseases", "post-nebulization", "IPRATROP LD RESPULES Nebulizer Solution", "IPRATROP LD RESPULES 2.5 ml", "levosalbutamol and ipratropium bromide respirator solution", "levosalbutamol ipratropium bromide nebulizer solution", "levosalbutamol with ipratropium bromide respules", "levosalbutamol ipratropium inhalation solution", "levosalbutamol and ipratropium combination nebulizer", "levosalbutamol ipratropium bromide respiratory solution uses", "levosalbutamol ipratropium bromide inhalation liquid", "what is levosalbutamol and ipratropium bromide respirator solution", "how does levosalbutamol ipratropium nebulizer work", "levosalbutamol ipratropium bromide for asthma", "levosalbutamol ipratropium bromide for copd", "benefits of levosalbutamol and ipratropium bromide solution", "levosalbutamol ipratropium bromide mechanism of action", "when to use levosalbutamol ipratropium nebulization", "levosalbutamol and ipratropium bromide dosage for adults", "levosalbutamol ipratropium nebulizer dosage in asthma", "levosalbutamol and ipratropium bromide side effects", "levosalbutamol ipratropium bromide common side effects", "is levosalbutamol ipratropium safe for long term use", "levosalbutamol ipratropium bromide precautions", "levosalbutamol ipratropium bromide drug interactions", "levosalbutamol ipratropium bromide for children", "evosalbutamol ipratropium nebulizer safety in children", "levosalbutamol and ipratropium bromide respirator solution price", "levosalbutamol ipratropium bromide respules price in india", "best levosalbutamol ipratropium bromide nebulizer solution", "levosalbutamol ipratropium bromide respirator solution manufacturer", "levosalbutamol ipratropium bromide wholesale supplier india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693410b5de5d3e57a934024e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Levosalbutamol Respiratory Solution 0.31 mg ", "description": "THEO-SLO LEVO LD Levosalbutamol Respiratory Solution 0.31 mg delivers targeted bronchodilation through nebulization, making it an essential therapy for asthma, COPD, and acute bronchospasm in adults and children. This low-dose formulation of the active R-isomer of salbutamol relaxes airway muscles swiftly, improving airflow and reducing symptoms like wheezing and shortness of breath. Ideal for patients needing gentle yet effective respiratory support, it ensures deep lung delivery via fine mist for optimal efficacy.​\n\nKey Uses of THEO-SLO LEVO LD Levosalbutamol Respiratory Solution 0.31 mg\nTHEO-SLO LEVO LD addresses obstructive airway diseases by directly targeting bronchial constriction. Primary indications include acute asthma attacks, chronic bronchitis, emphysema, and exercise-induced symptoms, where it restores normal breathing patterns efficiently.​\n\nAsthma Management: Relieves wheezing, chest tightness, and breathlessness during flare-ups or as maintenance therapy.​\n\nCOPD Support: Eases airflow restriction in chronic bronchitis and emphysema, enhancing daily activities.​\n\nAcute Bronchospasm: Provides fast intervention for triggers like allergens, infections, or pollutants.​\n\nExercise-Induced Relief: Prevents airway narrowing during physical exertion.​\n\nPediatric and Elderly Use: Nebulizer-friendly for young children or those unable to use inhalers.​\n\nAdministered via nebulizer, dilute as prescribed (typically 0.31 mg in 2-3 ml saline) for 5-10 minute sessions, 2-4 times daily based on severity.​\n\nKey Benefits of THEO-SLO LEVO LD Levosalbutamol Respiratory Solution 0.31 mg\nAs the purified R-isomer, Levosalbutamol in THEO-SLO LEVO LD offers higher potency and fewer side effects than racemic salbutamol, with rapid onset within minutes. Its nebulized form penetrates deeper into lungs, making it superior for severe cases or coordination-challenged patients.​\n\nQuick Bronchodilation: Relaxes smooth muscles to open airways, improving oxygen intake immediately.​\n\nEnhanced Tolerability: Lower cardiac stimulation reduces tachycardia risk compared to standard albuterol.​\n\nPatient-Friendly Delivery: Mist form suits infants, seniors, and acute distress without coordination needs.​\n\nSymptom Control: Decreases cough frequency, wheezing intensity, and respiratory distress for better quality of life.​\n\nLonger Relief Duration: Sustained action supports maintenance therapy alongside controllers like steroids.​\n\nClinical use shows improved lung function (FEV1 increase by 20-30%) and reduced hospitalization rates in responsive patients.​\n\nPotential Side Effects and Precautions for THEO-SLO LEVO LD\nTHEO-SLO LEVO LD remains well-tolerated at 0.31 mg, with most effects mild and transient. Monitor during initial use, especially in cardiac patients.​\n\nCommon Mild Effects: Tremors, nervousness, headache, or mild palpitations resolving quickly.​\n\nLess Frequent: Dry mouth, throat irritation, or muscle cramps from overuse.​\n\nRare Serious: Hypokalemia, paradoxical bronchospasm, or severe tachycardia—seek immediate care.​\n\nAvoid in hypersensitivity, uncontrolled arrhythmias, or with beta-blockers. Use cautiously in pregnancy (Category C), hyperthyroidism, diabetes, or hypertension; taper during weaning.​\n\nDosage Guidelines and Best Practices\nFor adults/children >12 years: 0.31-0.63 mg nebulized 3-4 times daily; children 2-12 years: half dose. Always dilute, use fresh solution, and clean nebulizer post-use. Combine with anti-inflammatories for chronic management; do not exceed recommended frequency.​\n\nConclusion: Breathe Easier with THEO-SLO LEVO LD Levosalbutamol Respiratory Solution 0.31 mg\nTHEO-SLO LEVO LD Levosalbutamol Respiratory Solution 0.31 mg transforms respiratory care by offering swift, reliable bronchodilation for asthma, COPD, and bronchospasm across age groups. Its selective action, nebulizer compatibility, and safety profile make it a cornerstone for symptom relief and lung health preservation. Consult healthcare providers for integrated therapy to achieve optimal breathing freedom and prevent exacerbations.​\n\n", "price": 306.0, "discountamount": 92.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2235, "imageuri": "https://productimages.withfloats.com/actual/693410b81213a99c808c771d.png", "tileimageuri": "https://productimages.withfloats.com/tile/693410b81213a99c808c771d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-06T11:17:09.692Z", "updatedon": "2026-04-06T12:53:19.949Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//levosalbutamol-respiratory-solution-0-31-mg-/2235", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "THEO-SLO LEVO LD", "category": "ASTHMA RANGE", "tags": [ "Levosalbutamol Respiratory Solution 0.31 mg", "nebulization", "improving airflow", "respiratory support", "therapy for asthma", "chronic obstructive pulmonary disease (COPD)", "levosalbutamol respiratory solution 0.31 mg uses", "levosalbutamol respiratory solution 0.31 mg dosage", "levosalbutamol respiratory solution 0.31 mg for nebulization", "levosalbutamol respiratory solution 0.31 mg for nebulization", "levosalbutamol respiratory solution 0.31 mg for children", "levosalbutamol respiratory solution 0.31 mg for asthma", "levosalbutamol respiratory solution 0.31 mg side effects", "levosalbutamol respiratory solution 0.31 mg price in india", "levosalbutamol 0.31 mg nebulizer solution uses", "what is levosalbutamol respiratory solution 0.31 mg", "how does levosalbutamol respiratory solution work", "levosalbutamol 0.31 mg nebulization benefits", "levosalbutamol respiratory solution for cough and cold", "best levosalbutamol respiratory solution 0.31 mg", "levosalbutamol respiratory solution 0.31 mg manufacturer", "levosalbutamol respiratory solution 0.31 mg supplier india", "buy levosalbutamol respiratory solution 0.31 mg online", "levosalbutamol 0.31 mg nebulizer dose for infants", "levosalbutamol respiratory solution 0.31 mg hospital use", "evosalbutamol nebulizer solution for pediatric asthma" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6926eb5b4c6b1fd261aeb36d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Levosalbutamol Respiratory Solution 0.63 mg", "description": "Levosalbutamol Respiratory Solution 0.63 mg is a fast-acting bronchodilator medication designed to relieve bronchospasm and improve breathing in conditions such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and other respiratory difficulties. Its active ingredient, levosalbutamol, works by relaxing the muscles lining the airways in the lungs, helping to open up the bronchial tubes and making it easier for air to flow through. This leads to quick reduction of symptoms such as wheezing, coughing, chest tightness, and shortness of breath, providing immediate relief during an asthma attack or respiratory flare-up.\n\nThe primary use of Levosalbutamol Respiratory Solution is to manage reversible obstructive airway diseases. It is especially effective during acute episodes of bronchospasm where rapid opening of the airways is necessary. Patients with asthma benefit from this solution as it reduces the intensity and frequency of attacks while improving overall lung function. It is also widely prescribed for COPD patients to alleviate persistent respiratory symptoms and prevent worsening of their condition. Delivered via nebulization, the solution ensures direct medication delivery to the lungs, maximizing therapeutic effects for quick symptom relief.\n\nKey benefits of Levosalbutamol Respiratory Solution 0.63 mg include:\n\nRapid bronchodilation resulting in immediate relief from airway constriction.\n\nImproved airflow and oxygen delivery enhancing breathing and physical activity tolerance.\n\nReduction in common respiratory symptoms like wheezing, coughing, and chest tightness.\n\nEffective management of both acute asthma attacks and chronic respiratory conditions.\n\nSuitable for use under medical supervision in adults and children aged four years and older.\n\nWhile Levosalbutamol is generally well-tolerated, some side effects may occur. Common mild side effects include tremors, nervousness, headache, dizziness, and palpitations. Gastrointestinal complaints like nausea or dry mouth can also be experienced occasionally. These effects are usually transient and resolve with continued use or dosage adjustment. More serious, though less frequent, side effects could include rapid or irregular heartbeats, chest pain, muscle cramps, or allergic reactions characterized by rash, swelling, or difficulty breathing. If any severe side effects arise, prompt medical attention is necessary.\n\nIn conclusion, Levosalbutamol Respiratory Solution 0.63 mg offers an effective and reliable treatment option for managing bronchospasm in asthma and COPD patients. Its mechanism of action ensures fast relief from breathing difficulties by relaxing airway muscles and enhancing airflow. When used as prescribed by healthcare professionals, it substantially improves the quality of life by controlling respiratory symptoms and preventing exacerbations. Patients should be mindful of potential side effects and follow dosage guidelines closely to maximize benefits while minimizing risks.\nThis respiratory solution by Steris Healthcare provides a safe, user-friendly option for individuals requiring quick bronchodilation and respiratory symptom management. It is part of a comprehensive asthma or COPD management plan that includes preventive therapies, lifestyle adjustments, and regular medical monitoring to optimize respiratory health.", "price": 369.0, "discountamount": 111.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2219, "imageuri": "https://productimages.withfloats.com/actual/6926eb5f71494d31a6ac98f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6926eb5f71494d31a6ac98f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-26T11:58:19.908Z", "updatedon": "2026-04-06T12:48:51.084Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//levosalbutamol-respiratory-solution-0-63-mg/2219", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "THEO-SLO LEVO 0.63", "category": "ASTHMA RANGE", "tags": [ "Levosalbutamol Respiratory Solution 0.63 mg", "chronic obstructive pulmonary disease", "respiratory symptoms", "coughing", "breathing", "levosalbutamol respiratory solution 0.63 mg", "levosalbutamol inhalation solution 0.63 mg", "levosalbutamol respules 0.63 mg", "levosalbutamol nebulizer solution 0.63 mg", "levalbuterol respiratory solution 0.63 mg", "levosalbutamol 0.63 mg nebulizer solution uses", "levosalbutamol respiratory solution dosage", "levosalbutamol respules for nebulization", "levosalbutamol inhalation solution for asthma", "levosalbutamol respules pediatric dose", "levosalbutamol respiratory solution how to use", "levosalbutamol respiratory solution price", "levosalbutamol 0.63 mg respules price in India", "levosalbutamol inhalation solution buy online", "levosalbutamol respules manufacturer", "what is levosalbutamol respiratory solution", "how levosalbutamol works in nebulizer", "when to use levosalbutamol respules" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6926e8de2d4e87382dc94ef6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Salbutamol Nebuliser Solution", "description": "Salbutamol Nebuliser Solution is a fast-acting medication widely used to provide quick relief from breathing difficulties caused by respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), bronchospasm, and exercise-induced bronchospasm. It works by relaxing the muscles around the airways in the lungs, allowing them to open up and enable easier airflow, thus alleviating symptoms like wheezing, chest tightness, shortness of breath, and coughing.\n\nThis nebuliser solution contains salbutamol sulfate, a selective beta-2 adrenergic receptor agonist, which targets the beta-2 receptors on the smooth muscles lining the bronchial tubes. By stimulating these receptors, salbutamol causes rapid relaxation of the bronchial muscles, leading to bronchodilation (airway expansion). The medication is administered via a nebuliser device that converts the solution into a fine mist, ensuring the drug reaches deep into the lungs for quick therapeutic effects, often within minutes.\n\nThe primary uses of Salbutamol Nebuliser Solution include emergency relief during acute asthma attacks, management of COPD symptoms, treatment of bronchospasm associated with various respiratory infections, and prevention of exercise-induced bronchospasm. It is essential in both hospital settings and at-home care, especially for patients who have difficulty using inhalers or require a higher dose administered over a longer inhalation period. This nebulised form also suits pediatric and elderly patients with respiratory distress.\n\nKey benefits of Salbutamol Nebuliser Solution are:\n\nRapid relief of airway obstruction and wheezing.\n\nImprovement in breathing comfort, oxygen supply, and chest tightness.\n\nEffective management of chronic respiratory diseases like asthma and COPD.\n\nPrevention of breathing difficulties triggered by exercise or allergens.\n\nEasy administration using nebuliser machines suitable for patients who cannot use standard inhalers.\n\nDespite its widespread use and efficacy, Salbutamol Nebuliser Solution may cause some side effects. Common side effects include tremors, nervousness, headache, dizziness, and palpitations due to its stimulation of beta receptors. Some users experience mild throat irritation or cough following nebulisation. In rare cases, serious side effects like rapid heart rate (tachycardia), chest pain, muscle cramps, or allergic reactions (rash, swelling, difficulty breathing) may occur. It is essential to use the medication under medical supervision, especially in patients with heart conditions, hypertension, diabetes, or thyroid disorders.\n\nIn conclusion, Salbutamol Nebuliser Solution is a reliable and essential bronchodilator for providing fast relief from respiratory distress caused by asthma, COPD, and bronchospasm. Its rapid onset, ease of use, and effectiveness in opening airways make it a cornerstone treatment in respiratory care. Proper use in the recommended doses combined with regular medical follow-up can significantly improve quality of life and reduce emergency hospital visits related to breathing difficulties.\n\nThis product is indispensable for patients dealing with chronic lung diseases or acute breathing emergencies, providing a vital therapeutic option that aids in maintaining healthy lung function and daily respiratory comfort.", "price": 40.0, "discountamount": 12.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2218, "imageuri": "https://productimages.withfloats.com/actual/6926e8e0b6275897c5d45de8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6926e8e0b6275897c5d45de8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-26T11:47:42.71Z", "updatedon": "2026-03-14T08:51:41.609Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//salbutamol-nebuliser-solution/2218", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "THEO-SLO SAL 2.5", "category": "ASTHMA RANGE", "tags": [ "Nebuliser", "chronic obstructive pulmonary disease", "coughing", "respiratory" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6880ce12b566f87e592f9db9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " Etophylline, Theophylline and Salbutamol Tablets", "description": "SLO THEO ES Tablets is a powerful triple-action bronchodilator formulation designed to provide relief from respiratory conditions such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), and other obstructive airway disorders. This unique blend of Etophylline, Theophylline, and Salbutamol works synergistically to relax the bronchial muscles, improve airflow, and reduce the severity and frequency of bronchospasms.\n\nBy combining etophylline and theophylline tablets with salbutamol, SLO THEO ES delivers a comprehensive respiratory support mechanism that not only opens up the airways but also helps in reducing inflammation and enhancing oxygen intake in the lungs. It is formulated to offer rapid relief while also supporting long-term control of respiratory symptoms.\n\nWhat is SLO THEO ES?\nSLO THEO ES is a combination medication containing etophylline 231 mg, theophylline 69 mg, and salbutamol 4 mg. Each of these components serves a specific function in easing breathing difficulties:\nEtophylline is a derivative of theophylline and acts as a bronchodilator with additional anti-inflammatory effects.\nTheophylline is a methylxanthine that relaxes the smooth muscles of the airways and improves diaphragm function.\nSalbutamol is a β2-adrenergic agonist that quickly relieves bronchospasm by relaxing airway muscles.\n\nThis combination makes SLO THEO ES highly effective for individuals who require both immediate and sustained bronchodilation.\nUses of SLO THEO ES Tablets:\nSLO THEO ES is prescribed for a range of chronic and acute respiratory conditions. It is especially beneficial in:\nBronchial asthma\nChronic Obstructive Pulmonary Disease (COPD)\nEmphysema\nChronic bronchitis\n\nAllergic bronchitis\n\nWheezing and breathlessness due to bronchospasm\n\nOther obstructive airway diseases\n\nThe etophylline and theophylline tablets in the formulation work on the central and peripheral pathways of the respiratory system, while salbutamol provides rapid symptom relief during acute attacks.\n\nSide Effects of SLO THEO ES Tablets:\nAs with most medications, SLO THEO ES may cause side effects, although not everyone experiences them. The most commonly reported side effects include:\n\nPalpitations\nNausea or vomiting\nRestlessness or anxiety\nTremors or shakiness\nInsomnia\nHeadache\nIncreased heart rate\n\nGastric discomfort\nSerious but rare side effects can include arrhythmias, severe hypotension, or seizures, especially if used in high doses or in sensitive individuals.\nPrecautions Before Using SLO THEO ES Tablets:\nBefore beginning treatment with SLO THEO ES, it is important to inform your doctor about your medical history, particularly if you have:\n\nHeart disease or high blood pressure\n\nHyperthyroidism\n\nPeptic ulcers\n\nSeizure disorders\n\nLiver or kidney impairment\n\nGlaucoma\n\nDiabetes mellitus\n\nPregnant or breastfeeding women should use SLO THEO ES only under medical supervision. Avoid alcohol or other stimulants that may enhance side effects. Do not exceed the prescribed dosage, and always follow the treatment duration recommended by your physician.\n\nDrug Interactions – What Drugs Interact with SLO THEO ES Tablets?\nSLO THEO ES may interact with several medications, altering their effectiveness or increasing the risk of adverse effects. Inform your healthcare provider if you are taking:\n\nBeta-blockers (e.g., propranolol)\n\nDiuretics (e.g., furosemide)\n\nOral contraceptives\n\nMacrolide antibiotics (e.g., erythromycin)\n\nAntiepileptic drugs (e.g., phenytoin, carbamazepine)\n\nFluoroquinolone antibiotics\n\nCimetidine (a gastric acid reducer)\n\nSteroids or other bronchodilators\n\nAlso, avoid consuming large quantities of caffeine, as both caffeine and theophylline belong to the same chemical class and can increase the risk of overstimulation.\n\nConclusion:\nSLO THEO ES Tablets offer an effective solution for managing obstructive respiratory conditions with its robust combination of etophylline, theophylline, and salbutamol. The synergistic action of these bronchodilators makes it an ideal choice for both acute symptom control and long-term respiratory support. However, due caution should be exercised regarding dosage, potential interactions, and side effects. Always consult your physician before starting or stopping this medication to ensure safe and effective use tailored to your condition.", "price": 95.0, "discountamount": 29.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2150, "imageuri": "https://productimages.withfloats.com/actual/6880ce15934b5c7d9f2ee4f8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6880ce15934b5c7d9f2ee4f8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-23T11:57:06.443Z", "updatedon": "2026-03-14T08:44:37.478Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//-etophylline-theophylline-and-salbutamol-tablets/2150", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SLO THEO ES TABLETS", "category": "ASTHMARANGE", "tags": [ "Etophylline, Theophylline and Salbutamol Tablets", "chronic obstructive pulmonary disease", "relief from respiratory" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66d826793838c070275d0ad0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Hyoscine Butylbromide tablet IP 10 mg", "description": "Introduction\n\nHyoscine Butylbromide Tablet IP 10 mg is a widely trusted antispasmodic medication used to relieve abdominal pain and discomfort caused by muscle spasms in the gastrointestinal, urinary, and reproductive systems. If you are dealing with sudden stomach cramps, intestinal spasms, or menstrual pain, this medicine offers fast and effective relief.\n\nKnown for its targeted action on smooth muscles, Hyoscine Butylbromide works by relaxing the muscles of the digestive tract and other organs, helping reduce pain and restore comfort. It is commonly recommended by healthcare professionals for conditions involving spasmodic pain, making it a reliable choice for both acute and recurring symptoms.\n\nFor buyers searching for a dependable solution for abdominal cramps or spasmodic discomfort, Hyoscine Butylbromide Tablet IP 10 mg stands out as a clinically proven and effective option.\n\nWhat is Hyoscine Butylbromide Tablet IP 10 mg?\n\nHyoscine Butylbromide Tablet IP 10 mg is an anticholinergic and antispasmodic medication. It is specifically designed to relieve smooth muscle spasms in various parts of the body without affecting the central nervous system significantly.\n\nThis medication is commonly used to treat:\n\nAbdominal cramps and pain\nIrritable bowel symptoms\nMenstrual cramps\nBladder spasms\nBiliary colic (pain related to gallbladder issues)\n\nIts ability to provide rapid relief from spasmodic pain makes it a preferred choice in both general and specialized medical practice.\n\nHow Hyoscine Butylbromide Works\n\nHyoscine Butylbromide works by blocking certain nerve signals that cause muscle contractions. These contractions are often responsible for spasms and pain.\n\nMechanism of Action:\nRelaxes smooth muscles in the gastrointestinal tract\nReduces involuntary muscle contractions\nDecreases pain signals associated with spasms\nHelps restore normal movement in affected organs\n\nBy targeting the root cause of spasms, it provides effective and long-lasting relief.\n\nKey Benefits of Hyoscine Butylbromide Tablet IP 10 mg\n1. Fast Relief from Abdominal Pain\n\nIt works quickly to reduce stomach cramps and discomfort caused by spasms.\n\n2. Effective in Irritable Bowel Conditions\n\nProvides relief from symptoms associated with Irritable Bowel Syndrome, such as cramping and bloating.\n\n3. Helps Manage Menstrual Cramps\n\nReduces pain and discomfort during menstruation by relaxing uterine muscles.\n\n4. Suitable for Multiple Conditions\n\nCan be used for gastrointestinal, urinary, and reproductive system spasms.\n\n5. Well-Tolerated Medication\n\nGenerally safe with minimal side effects when used as directed.\n\nWho Should Use This Medicine?\n\nHyoscine Butylbromide Tablet IP 10 mg is ideal for:\n\nIndividuals experiencing abdominal cramps or spasms\nPatients diagnosed with Irritable Bowel Syndrome\nWomen suffering from painful menstrual cramps\nPeople with bladder or urinary tract spasms\nPatients with gallbladder-related pain\n\nIt is suitable for both short-term and occasional use, depending on the condition.\n\nDosage and Administration\nRecommended Dosage\nAdults: Typically 10–20 mg, 3 to 4 times daily, or as prescribed by a doctor\nHow to Take\nSwallow the tablet whole with water\nCan be taken with or without food\nFollow the prescribed schedule for best results\nImportant Tips\nDo not exceed the recommended dose\nUse only as directed by a healthcare professional\nPossible Side Effects\n\nHyoscine Butylbromide is generally well tolerated, but some individuals may experience mild side effects.\n\nCommon Side Effects\nDry mouth\nDizziness\nBlurred vision\nConstipation\nRare Side Effects\nAllergic reactions\nIncreased heart rate\nDifficulty urinating\n\nIf you experience severe or persistent symptoms, seek medical advice immediately.\n\nPrecautions and Warnings\n\nBefore using Hyoscine Butylbromide Tablet IP 10 mg, consider the following:\n\n1. Medical Conditions\n\nAvoid use if you have:\n\nGlaucoma\nEnlarged prostate\nCertain heart conditions\n2. Pregnancy and Breastfeeding\n\nConsult your doctor before use.\n\n3. Driving and Machinery\n\nMay cause dizziness or blurred vision, so avoid driving if affected.\n\n4. Alcohol Use\n\nLimit alcohol consumption as it may increase side effects.\n\nDrug Interactions\n\nHyoscine Butylbromide may interact with:\n\nAntihistamines\nAntidepressants\nOther anticholinergic medications\n\nAlways inform your healthcare provider about all medicines and supplements you are taking.\n\nStorage Instructions\nStore in a cool, dry place\nKeep away from direct sunlight\nKeep out of reach of children\nBuyer’s Guide: Why Choose Hyoscine Butylbromide Tablet IP 10 mg?\n\nWhen purchasing an antispasmodic medication, buyers look for effectiveness, safety, and fast relief. This product offers:\n\nProven effectiveness for spasmodic pain\nRapid onset of action\nWide range of applications\nEasy-to-use tablet form\nTrusted by healthcare professionals\n\nChoosing a high-quality product from a reputable manufacturer ensures better safety and consistent results.\n\nLifestyle Tips for Better Results\n\nTo enhance the effectiveness of this medication:\n\nMaintain a balanced diet\nStay hydrated\nAvoid trigger foods that cause cramps\nPractice stress management techniques\nEngage in light physical activity\n\nThese habits can help reduce the frequency and severity of spasms.\n\nFrequently Asked Questions (FAQs)\n1. How quickly does Hyoscine Butylbromide work?\n\nIt usually starts working within 15–30 minutes after ingestion.\n\n2. Can it be used for menstrual pain?\n\nYes, it is highly effective in relieving menstrual cramps.\n\n3. Is it safe for long-term use?\n\nIt is generally used for short-term relief. Long-term use should be under medical supervision.\n\n4. Can I take it daily?\n\nYes, if prescribed by your doctor for a specific condition.\n\nConclusion\n\nHyoscine Butylbromide Tablet IP 10 mg is a reliable and effective solution for relieving spasmodic pain associated with abdominal cramps, Irritable Bowel Syndrome, and menstrual discomfort. Its fast-acting formula, broad range of uses, and favorable safety profile make it a preferred choice among patients and healthcare providers alike.\n\nFor buyers seeking immediate and effective relief from muscle spasms, this medication offers excellent value and performance. Always follow medical advice and recommended dosage for the best outcomes.\n", "price": 130.0, "discountamount": 39.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Dry Mouth", "usual dose", "full glass", "bile ducts", "brand name", "one tablet", "eye muscles", "Renal Colic", "other organs", "kidney stones", "major concern", "abdominal pain", "Blurred Vision", "smooth muscles", "bowel movements", "unusual symptoms", "Abdominal Cramps", "medical attention", "saliva production", "allergic reactions", "healthcare provider", "Common side effects", "Serious side effects", "painful muscle spasms", "gastrointestinal tract", "potential side effects", "healthcare professional", "genitourinary disorders", "various gastrointestinal", "Irritable Bowel Syndrome", "anticholinergic properties", "smooth muscle contractions", "severe gastrointestinal issues", "Hyoscine Butylbromide tablet IP" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1957, "imageuri": "https://productimages.withfloats.com/actual/69e71cded35d001d83aabe73.png", "tileimageuri": "https://productimages.withfloats.com/tile/69e71cded35d001d83aabe73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-04T09:20:57.67Z", "updatedon": "2026-05-16T08:17:56.987Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//hyoscine-butylbromide-tablet-ip-10-mg/1957", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "HYCOBUTYLE 10 ", "category": "GASTROLOGYRANGE", "tags": [ "Hyoscine Butylbromide Tablet Ip Uses", "Hyoscine Butylbromide Tablet Ip Uses In Hindi", "Hyoscine Butylbromide Tablet Ip Side Effects", "hyoscine butylbromide tablet uses", "hyoscine butylbromide tablet uses in hindi", "hyoscine butylbromide tablet", "hyoscine butylbromide tablet uses in hindi 10 mg", "hyoscine butylbromide tablet uses hindi", "hyoscine butylbromide tablet uses 10 mg", "hyoscine butylbromide tablet 10 mg", "hyoscine butylbromide tablet use", "hyoscine butylbromide tablet side effects", "hyoscine butylbromide tablet uses in tamil", "hyoscine butylbromide tablet 10mg", "hyoscine butylbromide tablet uses in gujarati", "hyoscine butylbromide tablet uses in hindi price", "hyoscine butylbromide tablet price in india", "hyoscine butylbromide tablet uses in telugu", "hyoscine butylbromide tablet uses 10 mg", "hyoscine butylbromide tablet adult dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a952bdada41ea9aeeec5e4a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide injection 8 mg", "description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.", "price": 7800.0, "discountamount": 2340.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2498, "imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:23:06.814Z", "updatedon": "2026-08-31T07:23:06.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 8MG", "category": "DIABETIC RANGE", "tags": [ "Semaglutide injection 8 mg", "semaglutide injection 8 mg", "semaglutide 8 mg injection uses", "semaglutide 8 mg injection benefits", "semaglutide 8 mg injection dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c35e76d1f6b0cbc0e2e40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 2 mg", "description": "SAMIGLUTIDE 2 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation is Semaglutide Injection 2 mg/3 mL (0.68 mg/mL). Semaglutide belongs to the GLP-1 receptor agonist class and is a prescription medicine that should be used only under the supervision of an appropriately qualified healthcare professional.\n\nSAMIGLUTIDE 2 MG Composition\n\nEach 3 mL pre-filled pen is stated to contain:\n\nActive substance: Semaglutide\nStrength: 2 mg/3 mL\nConcentration: 0.68 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute of administration: Subcutaneous, according to the applicable product instructions\n\nSemaglutide acts on GLP-1 receptors, which are involved in blood-glucose regulation and appetite control. The approved uses, dosage regimen and strength available can differ according to the specific product and the regulations of the country in which it is supplied.\n\nWhat Is Semaglutide?\n\nSemaglutide is a synthetic peptide that mimics the activity of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors, it can influence several physiological processes, including glucose-dependent insulin release, glucagon secretion, gastric emptying and appetite.\n\nThe appropriate dose and treatment schedule depend on the individual patient and the particular semaglutide formulation. Patients should follow their healthcare professional's instructions and should not alter the prescribed regimen independently.\n\nSAMIGLUTIDE 2 MG Pre-Filled Pen\n\nSAMIGLUTIDE 2 MG is presented as a pre-filled injection pen intended to provide a convenient method of administration when the medicine has been prescribed.\n\nSince semaglutide products can differ in concentration, pen design and dose-delivery mechanism, users should carefully verify the product label and prescribed dose before each administration. Particular care is important with injectable semaglutide products because differences in concentration or measurement methods can result in medication errors.\n\nPotential Medical Uses\n\nSemaglutide may be used for particular medical conditions depending on the formulation, regulatory approval and prescribing information applicable to the product.\n\nCertain approved semaglutide medicines are indicated for the treatment of type 2 diabetes, while other formulations have approved indications involving chronic weight management in eligible patients. Some products may also have additional approved indications for reducing specific cardiovascular risks.\n\nThe fact that semaglutide can be used for weight management does not mean that every semaglutide product is approved for that purpose. The authorization and labeling of SAMIGLUTIDE should therefore be confirmed from current official product documentation.\n\nHow Semaglutide Works\n\nSemaglutide activates GLP-1 receptors in the body. Its effects can contribute to improved regulation of blood glucose and reduced appetite and food intake. Depending on the approved indication, it may be prescribed together with dietary, physical-activity or other appropriate medical measures.\n\nIndividual responses can vary. Medical follow-up helps healthcare professionals evaluate treatment response, tolerability and whether treatment should be continued or modified.\n\nDosage and Administration\n\nSAMIGLUTIDE 2 MG should be administered only in accordance with the prescription and the manufacturer's current instructions.\n\nThe amount of semaglutide contained in a pen should not automatically be interpreted as the amount to inject at one time. Different products may use different concentrations, dose settings and administration schedules.\n\nFor approved semaglutide products, treatment may involve gradual dose increases for certain indications. Patients should never increase the dose, inject more frequently or repeat a missed dose without receiving appropriate medical instructions.\n\nPossible Side Effects\n\nSemaglutide can cause adverse effects, particularly gastrointestinal symptoms. Frequently reported effects may include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nAbdominal pain\n\nMore serious reactions are also possible. Product information for semaglutide medicines includes warnings relating to conditions such as pancreatitis and gallbladder disorders, among other potential risks.\n\nPersistent, severe or unusual symptoms should be discussed promptly with a healthcare professional. Patients should review the complete prescribing information supplied with their particular product.\n\nImportant Safety Information\n\nSemaglutide is not appropriate for everyone. For example, certain approved semaglutide products in the United States carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals with a serious hypersensitivity to semaglutide or an ingredient in the relevant product.\n\nThese precautions should not automatically be assumed to apply identically to every semaglutide product worldwide. The manufacturer's labeling and the regulatory requirements of the relevant country should always be consulted.\n\nPatients should inform their healthcare professional about their medical history and other medicines before starting treatment.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can make injectable treatment more convenient by providing the medication in a ready-to-use delivery device. When used according to the manufacturer's instructions, the pen may simplify administration and help patients maintain their prescribed treatment routine.\n\nPatients should nevertheless receive appropriate guidance regarding injection technique, storage, handling and disposal. The convenience of a pen does not eliminate the need for medical supervision.\n\nStorage and Handling\n\nSAMIGLUTIDE 2 MG should be stored exactly as stated on its packaging and official product information. Appropriate storage conditions are important for maintaining the quality and stability of the medicine.\n\nBefore use, check the expiry date and inspect the packaging and medicine according to the manufacturer's instructions. Do not use the product if the packaging is damaged or if the solution has an appearance that does not meet the stated product requirements.\n\nConclusion\n\nSAMIGLUTIDE 2 MG – Semaglutide Injection 2 mg/3 mL (0.68 mg/mL) is a semaglutide-based injectable formulation supplied in a pre-filled pen. Semaglutide is a GLP-1 receptor agonist with established medical applications for appropriately selected patients, depending on the specific product and its regulatory authorization.\n\nSafe use requires adherence to the prescribed dose and administration schedule. Patients should not independently change their dose or frequency and should seek professional advice if they experience concerning adverse effects.\n\nBecause formulations, indications, strengths and regulatory requirements can vary between products and countries, the current official package insert and applicable regulatory labeling should be used to verify product-specific information.\n\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 2 MG?\n\nSAMIGLUTIDE 2 MG is described as a semaglutide injection containing 2 mg of semaglutide in 3 mL, with a stated concentration of 0.68 mg/mL, supplied in a pre-filled pen.\n\nIs SAMIGLUTIDE 2 MG used for weight management?\n\nSemaglutide is included in certain approved medicines used for chronic weight management in eligible patients. However, the indication for a specific SAMIGLUTIDE product must be confirmed from its current regulatory approval and official labeling.\n\nHow frequently is SAMIGLUTIDE 2 MG injected?\n\nThe correct frequency depends on the specific product and the prescription issued by the healthcare professional. Patients should not determine the injection schedule based solely on the amount printed on the pen.\n\nCan SAMIGLUTIDE 2 MG be taken without medical supervision?\n\nNo. Semaglutide is a prescription medicine in many jurisdictions and should be obtained and used through legitimate, appropriately regulated healthcare channels.\n\nIs SAMIGLUTIDE the same as other branded semaglutide medicines?\n\nNot necessarily. Products containing semaglutide can differ in manufacturer, formulation, concentration, delivery device, regulatory approval and approved indications. A specific product should not be described as identical to an approved branded medicine unless that claim can be verified through reliable regulatory and product documentation.\n\nWhat should patients check before using the pen?\n\nPatients should verify the medicine name, strength, prescribed dose, expiry date, storage conditions and administration instructions. If there is any uncertainty about the dose or operation of the pen, they should consult their pharmacist, prescriber or another qualified healthcare professional rather than guessing.", "price": 5600.0, "discountamount": 1680.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2496, "imageuri": "https://productimages.withfloats.com/actual/6a8c35eaca4d2575d78e3716.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c35eaca4d2575d78e3716.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:15:35.873Z", "updatedon": "2026-08-24T12:15:35.873Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-2-mg/2496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 2 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }